BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17003643)

  • 1. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
    Pancreas; 2006 Oct; 33(3):233-9. PubMed ID: 17003643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in the operative and palliative treatment of pancreatic cancer.
    Talar-Wojnarowska R; Gasiorowska A; Strzelczyk J; Janiak A; Malecka-Panas E
    Neoplasma; 2003; 50(5):383-7. PubMed ID: 14628094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
    Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors influencing the long-term survival in pancreatic carcinoma patients after radical resection].
    Zhang WJ; Han SL; Jiang FZ; Zhu HL; Ye BL; Ke QH; Fang Y
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):870-2. PubMed ID: 19173836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of occult lymphatic tumor spread in pancreatic cancer].
    Milsmann C; Füzesi L; Werner C; Becker H; Horstmann O
    Chirurg; 2005 Nov; 76(11):1064-72. PubMed ID: 15971035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.
    Garcea G; Dennison AR; Ong SL; Pattenden CJ; Neal CP; Sutton CD; Mann CD; Berry DP
    Eur J Surg Oncol; 2007 Sep; 33(7):892-7. PubMed ID: 17398060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas.
    Mitsunaga S; Hasebe T; Iwasaki M; Kinoshita T; Ochiai A; Shimizu N
    Cancer Sci; 2005 Dec; 96(12):858-65. PubMed ID: 16367904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standard surgery as part of the multidisciplinary treatment for pancreatic cancer].
    Fujii Y; Ueda M; Yoshida K; Matsuo K; Takeda K; Morioka D; Tanaka K; Endo I; Togo S; Shimada H
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):177-81. PubMed ID: 16878410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical limitations of lymph node mapping in pancreatic cancer.
    Kocher HM; Sohail M; Benjamin IS; Patel AG
    Eur J Surg Oncol; 2007 Sep; 33(7):887-91. PubMed ID: 17433604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.